A world without malaria
Malaria is PHARMACEUTICALS the most common infectious disease worldwide, affecting some 200 million people each year. Fighting the spread of this disease calls for education, medicine, diagnostic equipment, mosquito netting and vaccine research. The Novartis Malaria Initiative has taken a lead role here. Since 2001, in collaboration with various organizations, the initiative has provided more than 850 million treatments – including 350 million for children – at cost and thus contributed to significantly reducing the death toll from malaria. While 839,000 people died from malaria in 2010, half as many deaths were associated with the tropical illness in 2016. Pictured: An infected cell.